Osteoporosis affects around 200 million people worldwide, with a particularly high prevalence among postmenopausal women. The condition often leads to weakened bones and an increased risk of fractures. The project aims to transform osteoporosis treatment — moving from maintenance and damage control to active regeneration and long-term bone strength. If successful, the project could provide surgeons with a new tool to improve patient outcomes, reduce healthcare costs, and restore quality of life for many.
The collaboration between the transatlantic team from the UC Davis Health Department of Orthopaedic Surgery and biomaterials experts from the Faculty of Dentistry at the University of Oslo combines decades of experience in regenerative medicine, clinical applications, and startup innovation. From UC Davis, Augustine Saiz and Maryam Rahmati contribute their unique expertise to the project.
Dean Tiril Willumsen from the Faculty of Dentistry expressed pride in the award: “This is a fantastic achievement. I am impressed by Håvard's work and the international collaboration that makes this research possible. This grant highlights the importance of innovative research and collaboration in addressing complex health challenges.”
The funding enables the team to further develop the technology and explore how peptide-encapsulated hydrogels can enhance the treatment of osteoporosis-related fractures, ultimately improving patients' lives.